2C-TFM
| Clinical data | |
|---|---|
| Other names | 2C-CF3; 2,5-Dimethoxy-4-trifluoromethylphenethylamine; 4-Trifluoromethyl-2,5-dimethoxyphenethylamine |
| Routes of administration | Oral |
| Drug class | Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen |
| Pharmacokinetic data | |
| Duration of action | ≥5–10 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H14F3NO2 |
| Molar mass | 249.233 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 260 °C (500 °F) (hydrochloride) |
| |
| |
| (verify) | |
2C-TFM, also known as 4-trifluoromethyl-2,5-dimethoxyphenethylamine or as 2C-CF3, is a serotonin 5-HT2 receptor agonist and psychedelic drug of the phenethylamine and 2C families. It was first synthesized in the laboratory of David E. Nichols. Later, it was tested in humans and its psychedelic effects were confirmed. 2C-TFM is the most potent psychedelic of the 2C psychedelics.